Talking Points and FAQs: Food and Drug Administration Recommends COVID-19 Vaccines for Kids Under Five (English, Spanish)

Talking Points and FAQs: Food and Drug Administration Recommends COVID-19 Vaccines for Kids Under Five (English, Spanish)

Date posted: June 21, 2022
Last reviewed: June 21, 2022

The Public Good Projects in collaboration with the Hispanic Communications Network

Talking points and FAQs provide information on the Pfizer and Moderna COVID-19 vaccines for children under 5 years old. The talking points discuss the vaccines' effectiveness among children and note that there were no cases of myocarditis in pediatric vaccine clinical trials. The talking points emphasize that while children typically have more mild cases of COVID-19 compared to adults, the vaccines protect children against the worst outcomes of COVID-19, like severe illness, hospitalization, and death. The FAQs cover similar information; they also highlight considerations for variant-specific vaccines in the future. A related graphic is available here: Social Media: Graphic About the Food and Drug Administration Recommending COVID-19 Vaccines for Kids Under Five (English, Spanish). Note: As of June 17, 2022, the Food and Drug Administration granted emergency use authorization to both vaccines for children as young as 6 months old, and as of June 18, 2022, the Centers for Disease Control and Prevention (CDC) recommended the vaccines for 6 months and older as well.

Download
Report